/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-07-26 18:24:192021-07-26 18:23:07Candel Therapeutics Announces Pricing of Initial Public Offering
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-05-11 05:00:172021-07-16 10:15:58Candel Therapeutics Names Carrie S. Cox as Chairman of its Board of Directors
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-29 05:00:212021-07-16 10:18:38Candel Therapeutics’ CAN-3110 Clinical Data Selected for Oral Presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-22 05:14:122021-07-16 10:20:04Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-13 05:04:502021-07-16 10:20:49Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
/wp-content/uploads/candel_logo.svg00cchan@candeltx.com/wp-content/uploads/candel_logo.svgcchan@candeltx.com2021-04-09 05:02:342021-07-16 10:21:41Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-12-08 08:00:532021-07-16 10:22:37Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-05-30 08:00:392021-07-16 10:23:32Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-05-18 08:00:012021-07-16 10:24:43Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting
/wp-content/uploads/candel_logo.svg00David Anderson/wp-content/uploads/candel_logo.svgDavid Anderson2020-01-08 08:00:542021-07-16 10:25:40Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
